Cargando…
Multiple myelomas in cats
Multiple myelomas are uncommon neoplasms of the bone marrow of cats [Weber NA, Tebeau CS (1998) An unusual presentation of multiple myeloma in two cats. Journal of the American Animal Hospital Association34 (6), 477–483]. Nine cats diagnosed with multiple myelomas were retrospectively identified ove...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ESFM and AAFP. Published by Elsevier Ltd.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130061/ https://www.ncbi.nlm.nih.gov/pubmed/16112593 http://dx.doi.org/10.1016/j.jfms.2004.12.005 |
_version_ | 1783516925733634048 |
---|---|
author | Hanna, Fikry |
author_facet | Hanna, Fikry |
author_sort | Hanna, Fikry |
collection | PubMed |
description | Multiple myelomas are uncommon neoplasms of the bone marrow of cats [Weber NA, Tebeau CS (1998) An unusual presentation of multiple myeloma in two cats. Journal of the American Animal Hospital Association34 (6), 477–483]. Nine cats diagnosed with multiple myelomas were retrospectively identified over a 16-year period (1986–2002). Cats with multiple myelomas were older than 7 years (mean age 11.7 years); six males and three females were affected (2.1), but no breed predisposition was evident. Treatment of multiple myelomas consisted of supportive management in the nine cats and anti-neoplastic therapy in eight cats. Supportive treatment consisted of maintaining hydration, renal function and antimicrobial therapy even when there was no sign of infection. Anti-neoplastic therapy with melphalan and prednisolone was carried out in eight cats. Three failed to respond to treatment and five responded to treatment, but the response was only partial and temporary in one cat. The five cats that responded were improved clinically and had reduced serum protein levels. Five out of eight cats (63%) responded to chemotherapy, and it appeared to be complete in four cats and partial in one cat. Survival time in those cats was 15, 4, 17 and 24 months. |
format | Online Article Text |
id | pubmed-7130061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | ESFM and AAFP. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71300612020-04-08 Multiple myelomas in cats Hanna, Fikry J Feline Med Surg Article Multiple myelomas are uncommon neoplasms of the bone marrow of cats [Weber NA, Tebeau CS (1998) An unusual presentation of multiple myeloma in two cats. Journal of the American Animal Hospital Association34 (6), 477–483]. Nine cats diagnosed with multiple myelomas were retrospectively identified over a 16-year period (1986–2002). Cats with multiple myelomas were older than 7 years (mean age 11.7 years); six males and three females were affected (2.1), but no breed predisposition was evident. Treatment of multiple myelomas consisted of supportive management in the nine cats and anti-neoplastic therapy in eight cats. Supportive treatment consisted of maintaining hydration, renal function and antimicrobial therapy even when there was no sign of infection. Anti-neoplastic therapy with melphalan and prednisolone was carried out in eight cats. Three failed to respond to treatment and five responded to treatment, but the response was only partial and temporary in one cat. The five cats that responded were improved clinically and had reduced serum protein levels. Five out of eight cats (63%) responded to chemotherapy, and it appeared to be complete in four cats and partial in one cat. Survival time in those cats was 15, 4, 17 and 24 months. ESFM and AAFP. Published by Elsevier Ltd. 2005-10 2005-04-26 /pmc/articles/PMC7130061/ /pubmed/16112593 http://dx.doi.org/10.1016/j.jfms.2004.12.005 Text en Copyright © 2005 ESFM and AAFP. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Hanna, Fikry Multiple myelomas in cats |
title | Multiple myelomas in cats |
title_full | Multiple myelomas in cats |
title_fullStr | Multiple myelomas in cats |
title_full_unstemmed | Multiple myelomas in cats |
title_short | Multiple myelomas in cats |
title_sort | multiple myelomas in cats |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130061/ https://www.ncbi.nlm.nih.gov/pubmed/16112593 http://dx.doi.org/10.1016/j.jfms.2004.12.005 |
work_keys_str_mv | AT hannafikry multiplemyelomasincats |